Home / Netherlands / Kiadis Pharma N.V.
Kiadis Pharma N.V.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
12 disclosures on record
Evolution of the disclosed total
0%1%
2025-13-01Apr 2026Jul 2026Oct 2026
October 15, 2018 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Kiadis Pharma N.V. by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| February 26, 2020 | Voleon Capital Management LP | 0.28% | |
| February 25, 2020 | Voleon Capital Management LP | 0.59% | |
| February 20, 2020 | Voleon Capital Management LP | 0.68% | |
| February 17, 2020 | Voleon Capital Management LP | 0.79% | |
| January 28, 2020 | Voleon Capital Management LP | 0.80% | |
| January 20, 2020 | Voleon Capital Management LP | 0.71% | |
| December 11, 2019 | Voleon Capital Management LP | 0.60% | |
| December 3, 2019 | Voleon Capital Management LP | 0.59% | |
| November 26, 2019 | Voleon Capital Management LP | 0.63% | |
| November 21, 2019 | Voleon Capital Management LP | 0.51% | |
| October 24, 2018 | GSA Capital Partners LLP | 0.42% | |
| October 15, 2018 | GSA Capital Partners LLP | 0.51% |
Download 12 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 12.38% of the capital sold short
- Signify N.V. 8.65% of the capital sold short
- Pharming Group N.V. 6.12% of the capital sold short
- Fugro N.V. 4.77% of the capital sold short
- Imcd N.V. 3.46% of the capital sold short
- Basic-Fit N.V. 2.79% of the capital sold short
- DSM-Firmenich AG 2.71% of the capital sold short
- Avantium N.V. 2.59% of the capital sold short
- Sligro Food Group N.V. 2.29% of the capital sold short
- TomTom N.V. 2.23% of the capital sold short
- PostNL N.V. 2.11% of the capital sold short
- NSI N.V. 1.90% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Kiadis Pharma N.V., source AFM, data as at February 26, 2020, https://www.quivad.com/action/kiadis-pharma-n-v